Gefitinib Teva

Gefitinib Teva is an oral medication used in cancer treatment. This pharmaceutical is designed to target specific proteins involved in cancer cell growth, offering a targeted approach to therapy.

Gefitinib Teva is primarily used in the treatment of certain types of cancer. It works by inhibiting the activity of specific proteins that are involved in the growth and spread of cancer cells. This medication is often prescribed for patients with non-small cell lung cancer that has specific genetic markers. The drug is part of a class of treatments known as tyrosine kinase inhibitors, which help to slow down the progression of cancer by interfering with the signals that tell cancer cells to grow and divide.

Common effects of Gefitinib Teva may include skin rash, diarrhea, and appetite loss. Some patients may also experience nausea, vomiting, or fatigue. These effects can vary in severity and may not affect everyone who takes the medication. It is important to discuss any persistent or bothersome side effects with a healthcare provider.

Gefitinib Teva should be handled with care and stored according to the manufacturer's instructions. It is important to follow the prescribed dosage and administration guidelines provided by a healthcare professional. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Pregnant women or those planning to become pregnant should consult their healthcare provider before using this medication.

Gefitinib Teva may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. This can affect the effectiveness of Gefitinib Teva or other medications. It is important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs, herbal supplements, and vitamins. Alcohol consumption should be discussed with a healthcare provider, as it may also interact with Gefitinib Teva.